Molecular karyotyping of multiple yeast species isolated from nine patients with AIDS during prolonged fluconazole therapy

Journal of Medical and Veterinary Mycology

Volumn 34, Issue 2, 1996, Pages 111-116

  Espinel Ingroff, A ^a,d   Quart, A ^b   Steele Moore, L ^c   Metcheva, I ^a   Buck, G A ^a   Bruzzese, V L ^a   Reich, D ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b North Central Bronx Hospital   (United States)

^c MEDICAL CENTER OF DELAWARE   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ADULT; ARTICLE; CANDIDA; CANDIDA ALBICANS; CLINICAL ARTICLE; DNA DETERMINATION; HUMAN; KARYOTYPING; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; SPECIES DIFFERENTIATION; TORULOPSIS GLABRATA; UNITED STATES; YEAST;

EID: 0029867918     PISSN: 02681218     EISSN: None     Source Type: Journal    
DOI: 10.1080/02681219680000171     Document Type: Article

References (23)

1. Stenderup A. Oral mycology. Acta Odont Scand 1990; 48: 3-10.
2. Stevens DA. Fungal infections in AIDS patients. Br J Clin Practice 1990; 44 (Suppl. 71): 11-22.
3. Boken DJ, Swindells S, Rinaldi MG. Fluconazole-resistant Candida albicans. Clin Infect Dis 1993; 17: 1018-21.
4. Bruatto M, Vidotto V, Marinuzzi G, Raiteri R, Sinicco A. Candida albicans biotypes in human immunodeficiency virus type 1-infected patients with oral candidiasis before and after antifungal therapy. J Clin Microbiol 1991; 29: 726-30.
5. Meunier F. Candidiasis. Eur J Clin Microbiol Inf Dis 1989; 8: 438-47.
6. Ng TTC, Denning DW. Fluconazole resistance in Candida in patients with AIDS - a therapeutic approach. J Inf 1993; 26: 117-25.
7. Redding SW, Farinacci GC, Smith JC, Fothergill AW, Rinaldi MG. A comparison between fluconazole tablets and clotrimazole troches for the treatment of thrush in HIV infection. Special Care Dent 1992; 12: 24-7.
8. Bart-Delabesse E, Boiron P, Carlotti A, Dupont B. Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole. J Clin Microbiol 1993; 31: 2933-7.
9. Lichewski A, Ruhnke M, Tennagen I, et al. Molecular epidemiology of Candida isolates from AIDS patients showing different fluconazole resistance profiles. J Clin Microbiol 1995; 33: 769-71.
10. Millon L, Manteaux A, Reboux G, et al. Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. J Clin Microbiol 1994; 32: 1115-8.
11. Pfaller MA, Rhine-Chalberg J, Redding SW, et al. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol 1994; 32: 59-64.
12. Redding S, Smith J, Farinacci G, et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in apatient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis 1994; 18: 240-2.
13. Asakura K, Iwaguchi S, Homma M, et al. Electrophoretic karyotypes of clinically isolated yeasts of Candida albicans and C. glabrata. J Gen Microbiol 1991; 137: 2531-8.
14. Lasker B A, Carle GF, Kobayashi GS, Medoff G. Comparison of the separation of Candida albicans chromosome-sized DNA by pulsed-field gel electrophoresis techniques. Nucl Acids Res 1989; 17: 3783-93.
15. Magee BB, Koltin Y, Gorman JA, Magee PT. Assignment of cloned genes to the seven electrophoretically separated Candida albicans chromosomes. Mol Cell Biol 1988; 8: 4721-6.
16. Magee PT, Bowdin L, Staudinger J. Comparison of molecular typing methods for Candida albicans. J Clin Microbiol 1992; 30: 2674-9.
17. Vollrath D, Davis RW. Resolution of DNA molecules greater than 5 megabases by contour-clamped homogeneous electric fields. Nucleic Acids Res 1987; 15: 7865-76.
18. Doebbeling BN, Lehmann PF, Hollis RJ, et al. Comparison of pulsed-field gel electrophoresis with isoenzyme profiles as a typing system for Candida tropicalis. Clin Infect Dis 1993; 16: 377-83.
19. Espinel-Ingroff A, Kerkering TM, Goldson PR, Shadoy S. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol 1991; 29: 1089-94.
20. Espinel-Ingroff A, Kish CW, Kerkering TM, et al. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol 1992; 30: 3138-45.
21. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing for yeasts: tentative standard M27-T. Villanova, PA: National Committee for Clinical Laboratory Standards, 1995.
22. Espinel-Ingroff A, Steele-Moore L, Galgiani JN. Evaluation of 80% inhibition standards for the determination of fluconazole minimum inhibitory concentrations in three laboratories. Diag Microbiol Inf Dis 1994; 20: 81-6.
23. Goff DA, Koletar SL, Buesching WJ, Barnishan J, Pass RJ. Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles. Clin Infect Dis 1995; 20: 77-83.